These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4038577)

  • 1. Treatment of gram-negative infections with aztreonam.
    Simons WJ; Lee TJ
    Am J Med; 1985 Feb; 78(2A):27-30. PubMed ID: 4038577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aztreonam in the treatment of bone and joint infections caused by gram-negative bacilli.
    Simons WJ; Lee TJ
    Rev Infect Dis; 1985; 7 Suppl 4():S783-8. PubMed ID: 2934786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aztreonam in the treatment of serious orthopedic infections.
    Pribyl C; Salzer R; Beskin J; Haddad RJ; Pollock B; Beville R; Holmes B; Mogabgab WJ
    Am J Med; 1985 Feb; 78(2A):51-6. PubMed ID: 3881949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aztreonam: worldwide overview of the treatment of patients with gram-negative infections.
    Henry SA; Bendush CB
    Am J Med; 1985 Feb; 78(2A):57-64. PubMed ID: 3881950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of aztreonam in the treatment of serious infections due to multiresistant gram-negative organisms, including Pseudomonas aeruginosa.
    Scully BE; Neu HC
    Am J Med; 1985 Feb; 78(2):251-61. PubMed ID: 4038574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current state of infectious diseases--potential areas of directed therapy with aztreonam.
    Neu HC
    Am J Med; 1985 Feb; 78(2A):77-80. PubMed ID: 4038580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of aztreonam in the treatment of serious gram-negative bacterial infections.
    LeFrock JL; Smith BR; Chandrasekar P; Rolston KV; Molavi A; Kannangara W
    Arch Intern Med; 1987 Feb; 147(2):325-8. PubMed ID: 3813751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Summary of worldwide clinical trials of aztreonam in patients with urinary tract infections.
    Swabb EA; Jenkins SA; Muir JG
    Rev Infect Dis; 1985; 7 Suppl 4():S772-7. PubMed ID: 3909336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aztreonam therapy for gram-negative pneumonia.
    Greenberg RN; Reilly PM; Luppen KL; Bollinger M; McMillian R
    Am J Med; 1985 Feb; 78(2A):31-3. PubMed ID: 3918444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of empiric aztreonam and aminoglycoside regimens in the treatment of serious gram-negative lower respiratory infections.
    Bjornson HS; Ramirez-Ronda C; Saavedra S; Rivera-Vázquez CR; Liu C; Hinthorn DR
    Clin Ther; 1993; 15(1):65-78. PubMed ID: 8458056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aztreonam therapy for serious gram-negative bacillary infections.
    Cone LA; Woodard DR
    Rev Infect Dis; 1985; 7 Suppl 4():S794-802. PubMed ID: 3909339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized clinical trial of aztreonam and aminoglycoside antibiotics in the treatment of serious infections caused by gram-negative bacilli.
    DeMaria A; Treadwell TL; Saunders CA; Porat R; McCabe WR
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1137-43. PubMed ID: 2679368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Aztreonam treatment of severe infections caused by gram-negative aerobic bacilli].
    Peter JD; Jehl F; Froehly S; Dupeyron JP; Monteil H; Rosset MA
    Pathol Biol (Paris); 1988 May; 36(5):525-30. PubMed ID: 3043352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of aztreonam in patients suffering from urinary tract infections with contraindications for the use of aminoglycosides.
    Fraschini F; Scaglione F; Alessandria M; Gattei G
    Chemioterapia; 1986 Oct; 5(5):319-21. PubMed ID: 3791478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of aztreonam therapy for serious infections due to gram-negative bacteria.
    McKellar PP
    Rev Infect Dis; 1985; 7 Suppl 4():S803-9. PubMed ID: 3909340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aztreonam therapy for complicated urinary tract infections caused by multidrug-resistant bacteria.
    Cox CE
    Rev Infect Dis; 1985; 7 Suppl 4():S767-71. PubMed ID: 3909335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of serious gram-negative infections with aztreonam.
    Greenberg RN; Reilly PM; Luppen KL; McMillian R; Bollinger M; Wolk SM; Darji TB; Noorani AA
    J Infect Dis; 1984 Nov; 150(5):623-30. PubMed ID: 6541672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy of ciprofloxacin therapy for gram-negative bacillary osteomyelitis.
    Hessen MT; Ingerman MJ; Kaufman DH; Weiner P; Santoro J; Korzeniowski OM; Boscia J; Topiel M; Bush LM; Kaye D
    Am J Med; 1987 Apr; 82(4A):262-5. PubMed ID: 3555045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of aztreonam for serious gram-negative bacterial infections.
    Raz R; Flatau E; Sudarsky M; Keness J
    Chemioterapia; 1988 Feb; 7(1):42-5. PubMed ID: 3378275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of low-dose aztreonam in the treatment of moderate to severe infections due to gram-negative bacilli.
    Clergeot A; Steru D; Rosset MA; Carbon C
    Rev Infect Dis; 1991; 13 Suppl 7():S648-51. PubMed ID: 2068476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.